[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Woloszczuk et al., 1986 - Google Patents

Determination of circulating monomeric katacalcin and calcitonin: physiological studies in normal subjects

Woloszczuk et al., 1986

View PDF
Document ID
13670689006942132091
Author
Woloszczuk W
Schuh H
Kovarik J
Publication year

External Links

Snippet

Katacalcin is a recently discovered peptide, contained within the calcitonin precursor. For the highly sensitive readioimmunological measurement of katacalcin and calcitonin we used extraction on C-18, thereby lowering the detection limits in seram to 0.8 pmol/1 (katacalcin) …
Continue reading at edoc.hu-berlin.de (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Fahrenkrug et al. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma
Blackburn et al. A radioimmunoassay for neurotensin in human plasma
Wood et al. Abnormalities of growth hormone release in response to human pancreatic growth hormone releasing factor (GRF (1-44)) in acromegaly and hypopituitarism.
Kiess et al. Specific growth hormone receptors on human peripheral mononuclear cells: reexpression, identification, and characterization
Sundsfjord et al. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man
Erisman et al. Human lung small-cell carcinoma contains bombesin.
Schwartz et al. Synchronous oscillations in the basal secretion of pancreatic-polypeptide and gastric acid: depression by cholinergic blockade of pancreatic-polypeptide concentrations in plasma
Zapf et al. Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.
MEGYESI et al. Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components
HIRATA et al. Plasma concentrations of immunoreactive human epidermal growth factor (urogastrone) in man
Heding et al. Determination of total serum insulin (IRI) in insulin-treated diabetic patients
Sarson et al. A radioimmunoassay of gastric inhibitory polypeptide in human plasma
Rasio et al. Diffusion of glucose, insulin, inulin, and Evans blue protein into thoracic duct lymph of man
TAKANO et al. Serum somatomedin peptides measured by somatomedin A radioreceptor assay in chronic liver disease
Naruse et al. Immunoreactive α-human atrial natriuretic polypeptide in human plasma
JPH0772146A (en) Method for measuring specificity of cardiogelatin, new peptide hormone and active piece of living organism
Sparagana et al. Ectopic growth hormone syndrome associated with lung cancer
Stalla et al. Ovine (o) and human (h) corticotrophin releasing factor (CRF) in man: CRF-stimulation and CRF-immunoreactivity
Itoh et al. Secretion of N-terminal fragment of gamma-human atrial natriuretic polypeptide.
GAVIN III et al. Radioreceptor assay of insulin: Comparison of plasma and pancreatic insulins and proinsulins
Sherman et al. Circulating insulin: the proinsulin-like properties of “big” insulin in patients without islet cell tumors
Botha et al. Gastric inhibitory polypeptide (GIP) in chronic pancreatitis
Nozuki et al. Plasma concentrations of atrial natriuretic peptide in various diseases
AKIHIRO et al. Evidence for cholinergic and vagal noncholinergic mechanisms modulating plasma motilin-like immunoreactivity
Amico et al. An oxytocin precursor intermediate circulates in the plasma of humans and rhesus monkeys administered estrogen